Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice

Diabetes

Volumn 47, Issue 6, 1998, Pages 961-966

  Ng, Donald Tat Fong ^a   Lee, Fuk Ki ^a   Song, Zhen Tao ^a   Calcutt, Nigel Alan ^b   Lee, Liu Wah ^a   Chung, Stephen S M ^a   Chung, Sookja K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IDITOL DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ENZYME DEFICIENCY; GENE MUTATION; IMMUNOBLOTTING; MOUSE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE;

ANIMALS; BRAIN; CATARACT; DIABETES MELLITUS, EXPERIMENTAL; FRUCTOSE; GLUCOSE; INOSITOL; INTRONS; KIDNEY; KINETICS; L-IDITOL 2-DEHYDROGENASE; LENS, CRYSTALLINE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEURAL CONDUCTION; POINT MUTATION; SCIATIC NERVE; SEMINAL VESICLES; SHEEP; SORBITOL; TESTIS;

EID: 2642616217     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.6.961     Document Type: Article

References (19)

1. Tomlinson DR: Aldose reductase inhibitors and the complications of diabetes mellitus. Diabet Med 10:214-230, 1993
2. Gabbay KH, Merola LO, Field RA: Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science 151:209-210, 1966
3. Tomlinson DR, Moriarty RJ, Mayer JH: Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Diabetes 33:470-476, 1984
4. Gabbay KH: Role of the sorbitol pathway in neuropathy. Adv Metab Disord 2:417-432, 1973
5. Greene DA, Lattimer SA: Action of sorbinil in diabetic peripheral nerve: relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Diabetes 33:712-716, 1984
6. Cameron NE, Cotter MA, Hohman TC: Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia 39:172-182, 1996
7. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
8. Tilton RG, Chang K, Nyengaard JR, Van den Enden M, Ido Y, Williamson JR: Inhibition of sorbitol dehydrogenase: effects on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes 44:234-242, 1995
9. Cameron NE, Cotter MA. Basso M, Hohman TC: Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 40:271-281, 1997
10. Lee FK, Chung SK, Chung SSM: Aberrant splicing causes sorbitol dehydrogenase deficiency in the C57BL/LiA mice. Genomics 46:86-92, 1997
11. Lal S, Szwergold BS, Taylor AH, Randall WC, Kappler F, Wells-Knecht K, Baynes JW, Brown TR: Production of fructose and fructose-3-phosphate in maturing rat lens. Ophthalmol Vis Sci 36:969-973, 1995
12. Holmes RS, Duley JA, Hilgers J: Sorbitol dehydrogenase genetics in the mouse: a null mutant in a 'European' C57BL strain. Anim Blood Groups Biochem Genet 13:543-550, 1982
13. Calcutt NA, Willars GB, Tomlinson DR: Statil-sensitive polyol formation in nerve of galactose-fed mice. Metabolism 37:450-453, 1988
14. Lee AYW, Chung SK, Chung SSM: Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci USA 92:2780-2784, 1995
15. Brownlee M: Nonenzymatic glycosylation of macromolecules: prospects of pharmacologic modulation. Diabetes 41 (Suppl. 2):57-60, 1992
16. Cameron NE, Cotter MA, Dines KC, Hohman TC: Reversal of defective peripheral nerve conduction velocity, nutritive blood flow and oxygenation by a novel aldose reductase inhibitor, WAY-12 1509, in streptozotocin-diabotic rats. J Diabetic Complications 10:43-53, 1996
17. Calcutt NA, Mizisin AP, Kalichiuan MW: Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve. Eur J Pharmacol 251:27-33, 1994
18. Whiteley SJ, Tomlinson DR: Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes. Exp Neurol 89:314-321, 1985
19. +-ATPase activity in galactose-fed mice. Diabetes 39:663-666, 1990